An Open Label, Randomized, Two Part Study to Evaluate the CYP2C8- and OATP1B1-Mediated Drug-Drug Interaction Potential of GSK1278863 With Pioglitazone and Rosuvastatin as Victims and Trimethoprim as Perpetrator in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 15 May 2017
At a glance
- Drugs Daprodustat (Primary) ; Pioglitazone (Primary) ; Rosuvastatin (Primary) ; Trimethoprim (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 11 May 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 19 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 27 Feb 2015 New trial record